SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008385
Filing Date
2023-05-08
Accepted
2023-05-08 07:59:32
Documents
72
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tgtx-20230331x10q.htm   iXBRL 10-Q 1509822
2 EX-10.1 tgtx-20230331xex10d1.htm EX-10.1 526306
3 EX-10.2 tgtx-20230331xex10d2.htm EX-10.2 116819
4 EX-10.3 tgtx-20230331xex10d3.htm EX-10.3 115291
5 EX-10.4 tgtx-20230331xex10d4.htm EX-10.4 120371
6 EX-10.5 tgtx-20230331xex10d5.htm EX-10.5 116345
7 EX-10.6 tgtx-20230331xex10d6.htm EX-10.6 116842
8 EX-10.7 tgtx-20230331xex10d7.htm EX-10.7 118672
9 EX-10.8 tgtx-20230331xex10d8.htm EX-10.8 122710
10 EX-31.1 tgtx-20230331xex31d1.htm EX-31.1 13515
11 EX-31.2 tgtx-20230331xex31d2.htm EX-31.2 13482
12 EX-32.1 tgtx-20230331xex32d1.htm EX-32.1 6650
13 EX-32.2 tgtx-20230331xex32d2.htm EX-32.2 6588
  Complete submission text file 0001558370-23-008385.txt   7148437

Data Files

Seq Description Document Type Size
14 EX-101.SCH tgtx-20230331.xsd EX-101.SCH 46168
15 EX-101.CAL tgtx-20230331_cal.xml EX-101.CAL 53379
16 EX-101.DEF tgtx-20230331_def.xml EX-101.DEF 154623
17 EX-101.LAB tgtx-20230331_lab.xml EX-101.LAB 363121
18 EX-101.PRE tgtx-20230331_pre.xml EX-101.PRE 269236
66 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20230331x10q_htm.xml XML 722173
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 23895898
SIC: 2834 Pharmaceutical Preparations